Trade Rocket Pharmaceuticals Inc - RCKT CFD
What is Rocket Pharmaceuticals Inc (RCKT)?
Rocket Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing gene therapies for rare inherited diseases. The company specializes in ex vivo lentiviral-based gene therapy approaches aimed at treating genetic disorders affecting the blood, heart, and muscle tissues. Its research pipeline includes therapies targeting conditions such as Fanconi anemia, Danon disease, and other rare genetic diseases. Rocket Pharmaceuticals employs advanced gene editing and gene transfer technologies to develop treatments intended to provide long-lasting therapeutic benefits. The company collaborates with academic institutions, research organizations, and industry partners to advance its clinical programs. Its work contributes to the broader field of gene therapy by addressing unmet medical needs in rare disease populations through innovative therapeutic solutions.
Rocket Pharmaceuticals Inc Stock Price Today: Live Overview
The price today is shaped by ongoing market movements, with Rocket Pharmaceuticals Inc priced at $3.56. It has fluctuated from $3.48 up to $3.7, reflecting a daily change percentage of -4.3836%.
FAQ: Rocket Pharmaceuticals Inc (RCKT)
What is the current price of RCKT stock?
Rocket Pharmaceuticals Inc is currently priced at $3.56.
Does RCKT pay dividends?
Rocket Pharmaceuticals Inc does not pay dividends.
Does RCKT have a formal corporate presence or regional headquarters in the UAE?
Rocket Pharmaceuticals Inc does not have a regional office or subsidiary in the UAE and operates via partners and distributors only.
What is RCKT best known for?
Rocket Pharmaceuticals Inc is most famous for its development of gene therapies for rare inherited diseases.
What assets are typically shown together with RCKT?
Commonly shown alongside RCKT: Inovio Pharmaceuticals, Global X Copper Miners UCITS ETF, UBS Global Gender Equality UCITS ETF
Latest shares articles



